TRAVERE THERAPEUTICS INC 2.25 03/01/2029 SDBCV

TRAVERE THERAPEUTICS INC 2.25 03/01/2029 SDBCV is a security (CUSIP 89422GAA5) tracked across SEC portfolio filings. 25 institutional managers reported $316.0M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $1.2M via N-PORT as of 2026-05-29.

Summary

Top institutional holders (Form 13F)

Showing 15 of 25 managers by value.

ManagerLocationValueShares
Linden Advisors LPNew York, NY$127.9M101,062,000
D. E. Shaw & Co., Inc.New York, NY$48.4M38,285,000
TENOR CAPITAL MANAGEMENT Co., L.P.NEW YORK, NY$40.4M32,000,000
ADVENT CAPITAL MANAGEMENT /DE/NEW YORK, NY$22.0M17,392,000
Graham Capital Management, L.P.ROWAYTON, CT$21.4M16,872,000
FMR LLCBOSTON, MA$13.7M10,852,000
SHENKMAN CAPITAL MANAGEMENT INCNEW YORK, NY$12.4M9,662,000
BlackRock, Inc.New York, NY$6.3M4,975,000
JANUS HENDERSON GROUP PLCLONDON, X0$6.0M4,779,000
GOLDMAN SACHS GROUP INCNEW YORK, NY$5.9M4,683,000
TWO SIGMA INVESTMENTS, LPNew York, NY$3.8M3,000,000
JPMORGAN CHASE & CONEW YORK, NY$2.2M1,797,000
AGF MANAGEMENT LTDTORONTO, A6$2.0M1,550,000
UBS Group AGZurich, V8$1.5M1,227,000
Kohlberg Kravis Roberts & Co. L.P.NEW YORK, NY$1.1M860,000

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Advent Convertible & Income FundADVENT CONVERTIBLE & INCOME FUND$904K15.21%
Franklin Alternative Strategies FundFranklin Alternative Strategies Funds$193K3.28%
MML VIP Fidelity Institutional AM Core Plus Bond FundMML SERIES INVESTMENT FUND$57K1.57%

More